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ABSTRACT 
Background & Aims: No reliable method for evaluating intestinal fibrosis in Crohn’s disease (CD) 
exists; therefore, we developed a computed-tomography enterography (CTE)–based radiomic model 
(RM) for characterising intestinal fibrosis in CD.  
Methods: This retrospective-multicentre study included 167 CD patients with 212 bowel lesions 
(training, 98 lesions; test, 114 lesions) who underwent preoperative CTE and bowel resection at one of 
the three tertiary referral centres from January 2014 through June 2020. Bowel fibrosis was 
histologically classified as none-mild or moderate-severe. In the training cohort, 1454 radiomic 
features were extracted from venous-phase CTE, and a machine learning–based RM was developed 
based on the reproducible features using logistic regression. The RM was validated in an independent 
external test cohort recruited from three centres. The diagnostic performance of RM was compared 
with two radiologists’ visual interpretation of CTE using receiver operating characteristic (ROC) 
curve analysis. 
Results: In the training cohort, the area under the ROC curve (AUC) of RM for distinguishing 
moderate-severe from none-mild intestinal fibrosis was 0.888 (95% confidence interval [CI]: 0.818–
0.957). In the test cohort, the RM showed robust performance across three centres with an AUC of 
0.816 (95% CI: 0.706–0.926), 0.724 (95% CI: 0.526–0.923), and 0.750 (95% CI: 0.560–0.940), 
respectively. Moreover, the RM was more accurate than visual interpretations by either radiologist 
(#1 AUC=0.554; #2 AUC=0.598; both P<0.001) in the test cohort. Decision curve analysis showed 
that the RM provided a better net benefit to predicting intestinal fibrosis than the radiologists. 
Conclusion: A CTE-based RM allows for accurate characterisation of intestinal fibrosis in CD. 
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INTRODUCTION 
Fibrostenosis is a serious complication of Crohn’s disease (CD) affecting approximately half of all 
patients.1, 2 Excessive collagen deposition within the bowel wall is the main feature of CD fibrosis. 
Fibrosis and inflammation typically coexist in the affected intestine, and current anti-inflammatory 
therapies used in CD cannot effectively prevent or reverse establi hed intestinal fibrosis.3 CD 
fibrostenosis is typically treated with surgical resection. Hence, accurate characterisation of intestal 
fibrostenosis is crucial for managing patients with CD.1 As transmural fibrosis is not discernible by 
endoscopic visualisation or partial-thickness biopsy, cross-sectional imaging has been explored as a 
non-invasive alternative for characterising fibrostenosis.4 Emerging imaging techniques such as 
magnetisation transfer magnetic resonance imaging (MRI)5-7 and ultrasonic elastography8 are 
reportedly able to accurately assess intestinal fibros s. However, the interobserver variation and 
subjectivity of magnetisation transfer MRI and the operator level dependence of ultrasonic 
elastography are of concern when using these techniques in clinical practice.9 To date, there is no 
consensus on the most reliable method for evaluating intestinal fibrosis in CD. 
Computed tomography enterography (CTE) is a widely used imaging modality for CD; however, it 
lacks accuracy in detecting intestinal fibrosis.1, 10, 11 The conventional visual interpretation on CTE 
images may not be sufficient for full and objective evaluation of lesion features, which may 
underestimate CTE’s ability to assess intestinal fibrosis. Recently, radiomics, which involves 
computer-based extraction of large amounts of high-dimensional features from medical images, has 
been explored to overcome these limitations.12, 13 It can uncover disease characteristics that may not be 
detected by visual inspection of images. Radiomics has been used in colorectal cancer studies14-18 but 
could potentially be applied to other digestive disea es including CD. Few studies have used radiomics 
to assess CD.19, 20 Tabari et al.19 recently reported that texture analysis of contrast-enhanced MRI can 
detect bowel fibrosis in CD. Although this study involved inherent limitations (e.g. it only included 25
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radiomics analysis of cross-sectional imaging for assessing intestinal fibrosis. However, feature 
extraction from MRI is more complex and less reproducible than that from CT images, indicating that 
the results from Tabari et al. may not be easily reproducible on another cohort.21 To our knowledge, no 
study has investigated the efficacy of radiomic CT analysis for evaluating intestinal fibrosis in adults 
with CD. 
This multicentre study developed and externally validated a CTE-based radiomic model (RM) to 
characterise intestinal fibrosis in CD and compared its capability with radiologist-performed visual 
interpretation of CTE images. We hypothesised that different levels of collagen deposition in 
fibrostenosis lead to a distinct contrast-enhanced pattern on the bowel wall on CTE in ways that might 
be detectable by radiomics but may not be visually apparent; thus, radiomics may provide better 
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MATERIALS AND METHODS 
Patients and study design 
This retrospective multicentre study, which included 167 consecutive eligible patients with CD from 
three tertiary referral centres in China from January 2014 through June 2020, was approved by the 
institutional ethics review board of The First Affiliated Hospital of Sun Yat-Sen University, which 
waived the requirement for informed consent. The training cohort was recruited from The First 
Affiliated Hospital of Sun Yat-Sen University (Centre 1) while the external test cohort involved 
patients from Centre 1, The Sixth Affiliated Hospital of Sun Yat-Sen University (Centre 2), and 
Nanfang Hospital of Southern Medical University (Centr  3).  
The inclusion criteria were as follows: (a) available preoperative abdominal and pelvic CTE within 3 
months of surgery for bowel strictures or fistula/abscess; and (b) availability of a histopathologic 
surgical specimen of a segment of intestine corresponding to a matching abnormality on CTE. The 
exclusion criteria were as follows: (a) inadequate imaging quality resulted from breathing artifact; (b) 
targeted bowel segment located at an anastomosis becaus  the natural imaging features of anastomosis 
would be changed by the medical intervention; (c) not readily identifiable intestinal contour on CTE 
due to severe perienteric effusion, intestinal adhesion or intestinal peristalsis; or (d) emergency surgery 
without enhanced-CT scanning (Fig. 1).  
The final training cohort included 87 patients (62 men, 25 women; mean age: 34.36±11.89 years) 
with 98 bowel segments. The final test cohort included 80 patients (55 men, 25 women; mean age: 
34.19±11.41 years) with 114 bowel segments. The demographic and clinical characteristics of the 
training and test cohort are shown in Table 1. 
 
Reference standard for intestinal fibrosis 
Matched radiological and surgical evaluation was performed as previously reported5, 22 by a 
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(e.g. location, length, and stricture) were reviewed in surgical and pathological records to ensure that 
the same lesions were analysed in cases of patients with multifocal intestinal involvement,22 or the 
anatomic location of target areas was documented with respect to defined anatomic landmarks (e.g. 
ileocecal valve or appendix) in the operating room.5 The detailed information is shown in the 
Supplementary materials. The histologic sections from three centres were assessed using the same 
criteria by a pathologist (Q.C., with 10 years of exp rience in bowel pathology) who was blinded to 
clinical and radiological information. The pathologist graded the bowel fibrosis on Masson’s 
trichrome section and bowel inflammation on haematoxylin and eosin section from 0 to 4 using a 
semi-quantitative scoring system (Supplementary Table 1).10 Histologic fibrosis and inflammation 
scores were categorised in none-mild (scores, 0–2) or moderate-severe (scores, 3–4) groups.23 The 
histologic fibrosis and inflammation scores of both cohorts are shown in Supplementary Table 2. 
 
CTE examination and radiologist-performed visual interpretation of intestinal fibrosis on CTE 
images 
All patients underwent preoperative CTE using one of the five CT scanners (Supplementary 
materials) in three centres. On plain and dual-phase enhancement CTE, two radiologists (X.L. and 
S.H., with 10 and 8 years of experience in abdominal CT, respectively) unaware of pathological and 
radiomic data separately assessed intestinal fibrosis based on the following three traits3, 4, 11, 24: lumen 
narrowing; pre-stricture dilation; iso-density or mildly progressive pattern after enhancement 
(imaging-feature definitions in Supplementary Table 3). The observation result of each imaging 
feature was recorded as a score, of which ‘0’ refers to absence and ‘1’ to presence (Supplementary 
Table 4). The kappa statistic was calculated to determine interobserver agreement between the two 
radiologists. The diagnostic performance of radiologist-performed visual interpretation was evaluated 
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The logistic regression models established with radiologist-performed visual interpretation are shown 
in the Supplementary materials. 
 
Volume-of-interest (VOI) segmentation and radiomic feature extraction and selection 
Similar to other bowel radiomics studies,14, 19 we selected contrast-enhanced venous-phase bowel 
images for radiomics analysis. Three-dimensional VOIs of the bowel lesions in the training and test 
cohorts were manually segmented on the venous-phase CT images by a radiologist (J.M., with 4 years 
of experience in abdominal CT), using an open-source medical imaging software (MITK, version 
2018.04; https://www.mitk.org/). The VOIs were drawn along the lesion contour on each transverse 
section until the full lesion was captured excluding the intestinal lumen. The completed VOIs were 
used as a mask to select the voxels that encompassed the lesion.  
To investigate the inter- and intra-observer reproducibility of extracting radiomic features, two 
radiologists (B.L. with 7 years of experience in abdominal CT, and J.M.) undertook additional VOI 
segmentation that consisted of 61 bowel segments in the test cohort recruited from Centre 1 using the 
same tool and environment settings. The time interval between two readings of one radiologist (J.M.) 
was over 6 months. The average time to manually segment one VOI by the radiologists was 4.73±3.40 
minutes. Intraclass correlation coefficients (ICCs) were calculated from a two-way random effects 
model to determine the inter- and intra-observer reliability. Only radiomic features that had excellent 
reliability (ICC>0.90) were considered robust.25 
Radiomic features extraction was performed using in-house software developed in MATLAB 
(version R2018a; https://www.mathworks.org/). Within each VOI, three wavelet transforms 
(Daubechies, Coiflets, and Symlets) with three different ratios (0.5, 1.5, and 2.0) between lowpass 
(approximation) and high-pass (detail) components were performed on the original image (10 images 
in total). Next, 24 shape features that assessed the spatial properties of three-dimensional VOI were 
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features were calculated on the 10 images, resulting in (37+106)×10=1430 features. In total, 1454 
radiomic features were available for each VOI (Supplementary materials). 
To reduce the dimensionality and select the best subset of features, the following feature selection 
strategies were used: (a) Selecting features that were under a significance lev l of 0.1 in differentiating 
none-mild and moderate-severe intestinal fibrosis in the training cohort according to univariate 
analysis; (b) The least absolute shrinkage and selection operator (LASSO) of logistic regression 
model,26 with penalty tuning conducted by 10-fold cross-valid tion, was applied to select 
fibrosis-related features (Supplementary materials). 
To investigate the utility of radiomic features forcharacterizing the spatial variation of fibrosis 
within the bowel strictures, feature maps of selectd features were generated using voxel-based 
radiomics analysis. The VOI for each subject was used to limit the calculation of local feature values. 
Radiomic features were calculated in smaller blocks with a kernel radius of three pixels throughout the 
VOI, and the values were assigned to the centre pixl. 
 
Radiomic model development in the training cohort and validation in the test cohort 
A binary classification RM model was built for distinguishing between none-mild and 
moderate-severe intestinal fibrosis based on the selected radiomic features by using logistic regression. 
Logistic regression is a machine learning algorithm ai ing to find the best fit of a logistic function that 
is diagnostically reasonable to describe the relationship between target and predictor variables. To 
avoid overfitting and select the best parameters for the diagnostic model, we conducted leave-one-out 
cross-validation (LOOCV) in the training cohort. In the training procedure of this LOOCV, a grid 
search method was used to determine the optimal parmeters made of C (inverse of regularisation 
strength), max_iter (maximum number of iterations taken for the solvers to converge), and tol setting 
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in the training cohort was assessed based on all probabilities of testing samples in each fold during 
cross-validation.  
The validation of the RM was performed using the same metrics in the completely independent test 
cohort recruited from Centres 1–3. The logistic regression model, built on the training cohort using the 
optimal parameters and selected features, was then applied to the test cohort.  
The performance of the diagnostic model was evaluated using the area under the receiver operating 
characteristic (ROC) curve (AUC) and by performing calibration using the Hosmer–Lemeshow 
goodness-of-fit test. Model development was performed in the Python environment (version 3.6; 
https://www.python. org/) using the Scikit-learn pack ge (version 0.22; https://www.scikit-learn.org/). 
Our radiomics analysis workflow is presented in Fig. 2 and detailed in the Supplementary materials.  
 
Stratification analysis of radiomic model’s diagnostic performance  
Given that inflammation and fibrosis often coexist in he intestinal strictures in CD,5 evaluation of 
RM’s ability to assess intestinal fibrosis in different degrees of inflammation is necessary. To address 
this issue, the diagnostic performance of the RM was compared between the bowel walls with 
moderate-severe inflammation and those with none-mild inflammation. Additionally, studies have 
suggested that small bowel CD and colonic CD represent two distinct disease entities.28-30 Therefore, 
the difference in the diagnostic performance of the RM between small bowel strictures and colonic 
strictures is worthy of exploration. We also investiga ed the differences in the diagnostic efficiency of 
the RM between different CT scanners and between bowel strictures with and without penetrating 
diseases, to assess its stability and robustness. The penetrating diseases were evaluated based on 
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Clinical utility of radiomic model and radiologist-performed visual interpretation 
Decision curve analysis was used to measure the clinical utility of the RM and radiologist-performed 
visual interpretation; a decision analytic measure called net benefit of the model was calculated for 
each possible threshold probability by summing the benefits (proportion of true-positive) and 
subtracting the harms (proportion of false-positive), weighting the latter by the relative harm of a 
false-positive and a false-negative result.31 The net benefit values of the diagnostic models were 




A sample size of at least 26 bowel lesions (13 none-mild and 13 moderate-severe fibrosis) was 
required in the training and test cohorts based on the following input and assumption: power, 80%; 
two-sided significance level, 0.05; alternative hypothesis of the AUC, 0.800, compared with the null 
hypothesis of the AUC, 0.500, and an allocation ratio of sample sizes in the negative and positive 
groups of 1.32 Therefore, sample sizes of 98 (33 none-mild and 65 moderate-severe fibrosis) in the 
training cohort and 114 (32 none-mild and 82 moderate-severe fibrosis) in the test cohort were 
sufficient to detect an AUC different from 0.500 with 80% power if the true AUC was above 0.800. 
 
Diagnostic performance 
Normally distributed data are expressed as mean ± standard deviation, and non-normally distributed 
data are presented as median (interquartile range [IQR]). The differences in radiomic features, clinical 
characteristics, and histologic scores between none-mild and moderate-severe intestinal fibrosis were 
calculated with Student’s t-test, Welch’s t-test, or Mann–Whitney U-test according to the data 
distribution. A bivariate correlation analysis betwen radiologist-performed visual interpretation and
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performances of the RM and radiologist-performed visual interpretation were evaluated by the ROC 
curve and AUC value, reported with corresponding 95% confidence interval (CI). An AUC of 0.50–
0.69 was considered mild, 0.70–0.89 moderate, 0.90–1.0  good. The accuracy, sensitivity, and 
specificity were calculated from the ROC curve according to the cut-off value that maximises the 
Youden index, equal to sensitivity + specificity - 1. Paired and unpaired ROC curves between different 
models were compared using the DeLong method.33, 34 The calibration performances of the models 
were assessed using the Hosmer–Lemeshow goodness-of-fit test. Statistical analysis was performed in 
Python and R (version 3.6.3; https://www.r-project.org/) environments. A two-sided P<0.05 was 
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RESULTS 
Radiomic feature selection and model development 
Radiomic feature selection 
Of the 1454 radiomic features extracted from the training cohort, 127 that were significantly 
different between none-mild and moderate-severe intesti al fibrosis were considered for the following 
analysis. Subsequently, the optimised  parameter (the weight of L1-term in LASSO, and determined 
by 10-fold cross-validation) was used to build the LASSO model and four fibrosis-related features 
were selected based on the training cohort (Supplementary Fig. 1A–B). The four selected features 
were all Busyness based on Neighbourhood Grey Tone Difference Matrix (NGTDM) on four different 
images (original image and three wavelet-transformed images). Details on the selected radiomic 
features are provided in Supplementary Table 5. The heatmap of selected features in both cohorts is 
shown in Supplementary Fig. 1C–D. 
 
Inter- and intra-observer reproducibility of extracting radiomics features 
Among the 1454 features, 60 with zero variance were excluded. The median ICCs of the other 1394 
radiomic features for inter- and intra-observer agreement assessment were 0.985 (IQR, 0.965–0.993) 
and 0.988 (IQR, 0.968–0.996) respectively, suggesting marked reliability of the radiomic features. The 
four selected features in our RM also showed robust inter- and intra-observer reproducibility, with 
ICCs ranging from 0.977 to 0.998 (all P<0.001) and from 0.963 to 0.997 (all P<0.001), respectively. 
 
Radiomic model development 
A logistic regression model was built in the training cohort and then applied to the test cohort. The 
outcome of the RM was generated as a function of a line r combination of the four selected features 
weighted by their respective coefficients using the logistic function. The outcome is a value between 








Downloaded for Philip O'Reilly (philip.oreilly@uhb.nhs.uk) at University Hospitals Birmingham NHS Foundation Trust from ClinicalKey.com by Elsevier on March 02, 2021.
For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.
16 
 
 =  
1
1 + 
 ,  
 = −4.2393 × "#$##%&''()* + 0.4272 × "#$##-%'./&01 + 6.1727 × "#$##345&01
− 0.2293 × "#$##345&51 + 0.00196 × 107 
where "#$##%&''()* is the Busyness value of the original image, "#$##-%'./&01 is the 
Busyness value of the image transformed with the Coiflets wavelet and a compression ratio of 0.5, 
"#$##345&01 and "#$##345&51 are the values of Busyness on the Daubechies-transformed 
image with compression ratios of 0.5 and 1.5, respectively. The Busyness measures the spatial 
frequency of intensity changes from one pixel to its neighbours. A higher value of Busyness indicates a 
‘busy’ image, with rapid changes in intensity between pixels and its neighbourhood.35 Fig. 3A and Fig. 
3B show images of representative patients with moderate-severe and none-mild bowel fibrosis, 
respectively, on CTE and relevant Busyness feature maps overlaid on venous-phase images. 
 
Diagnostic performance of the radiomic model in the training and test cohorts 
The predicted probabilities of our RM for each bowel lesion in both cohorts are provided in Fig. 4A–
B. With LOOCV, the RM predicted intestinal fibrosis with an AUC of 0.888 (P<0.001) in the training 
cohort (Table 2). 
In the multicentre validation, our RM exhibited a sati fied performance for predicting intestinal 
fibrosis both in the combined test cohort (AUC=0.832; P<0.001; Table 2) and in each single centre 
(AUC=0.816, 0.724, 0.750, respectively; Fig. 4C; Table 3). There were no significant differences in 
the AUC among the three centres (all P>0.400). 
No significant difference in the AUC was observed btween the training cohort and the total test 
cohort according to DeLong’s test (P=0.331), suggesting considerable efficacy and robustnes  of our 
RM (Fig. 4D). The Hosmer–Lemeshow test yielded a χ2 value of 8.997 (P=0.343) and 11.006 
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Comparison of diagnostic performance of the radiomic model and radiologist-performed visual 
interpretation 
There were positive correlations between lumen narrowing and histologic fibrosis scores in the test 
cohort (radiologist 1: Kendall’s τb=0.226, P=0.015; radiologist 2: Kendall’s τb=0.250, P=0.007) but 
not in the training cohort (radiologist 1: Kendall’s τb=0.052, P=0.606; radiologist 2: Kendall’s 
τb=-0.044, P=0.664). No significant correlation was found between histologic fibrosis scores and 
either pre-stricture dilation or enhancement pattern in the training and test cohorts (Kendall’s 
τb=-0.148-0.163; all P>0.05). 
As shown in Table 2, two radiologists’ visual interpretation showed poor diagnostic performance for 
differentiating varying degrees of intestinal fibrosis (radiologist 1: AUC=0.508; P=0.892; radiologist 
2: AUC=0.567; P=0.281) in the training cohort. The RM significantly outperformed visual 
interpretation by both radiologist 1 (AUC=0.888 vs.0.508, P<0.001) and radiologist 2 (AUC=0.888 
vs. 0.567, P<0.001) in diagnosis of intestinal fibrosis (Fig. 4F). The decision curve (Fig. 4G) showed 
that, if the threshold probability is approximately over 20%, the RM had a higher net benefit than the 
radiologists’ visual interpretation in the training cohort, indicating better performance of the RM in 
terms of clinical application. 
In the test cohort, the diagnostic performance of the RM in differentiating moderate-severe from 
none-mild intestinal fibrosis was also significantly higher than that of the radiologists’ visual 
interpretation (radiologist 1: AUC=0.554; P=0.354; radiologist 2: AUC=0.598; P=0.071) (both 
P<0.005 for DeLong’s test; Fig. 4H). The decision curve analysis (Fig. 4I) in the test cohort showed 
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Diagnostic performances of radiomic model in different inflammatory severity, different CD 
locations, different CT scanners, and bowel strictures with and without penetrating diseases 
In different inflammatory severity--In the training cohort, the bowel lesions were categorised as 
none-mild inflammatory segments (16.33%, 16/98) or m derate-severe inflammatory segments 
(83.67%, 82/98) based on their histologic inflammation scores (Supplementary Table 2). As shown in 
Table 2, the RM achieved a moderate diagnostic effiacy for differentiating moderate-severe from 
none-mild fibrosis in bowel walls with none-mild inflammation (AUC=0.836; P=0.010) or those with 
moderate-severe inflammation (AUC=0.890; P<0.001). No significant difference in the RM’s AUC 
for diagnosing fibrosis was found between these subgroups (P=0.702). 
In the test cohort, 43 bowel segments were in none-mild inflammation (37.72%, 43/114) and 71 in 
moderate-severe inflammation (62.28%, 71/114) (Supplementary Table 2). The RM had moderate 
diagnostic efficacy for differentiating varying degr es of fibrosis in bowel walls with none-mild 
inflammation (AUC=0.829; P<0.001) or those with moderate-severe inflammation (AUC=0.785; 
P<0.001) (Table 2). No significant difference in the RM’s AUC for diagnosing fibrosis was found 
between these subgroups (P=0.662). 
In different CD locations--No significant differences in the AUC of the RM for differentiating 
varying degrees of fibrosis were found between the small bowel strictures and colonic strictures in 
either the training or test cohort (P=0.569, 0.810, respectively) (Supplementary Fig.2, Supplementary 
Table 6). 
In different CT scanners--No significant differences in the AUC of the RM for differentiating 
varying degrees of fibrosis were shown between different CT scanners in either cohort (all P>0.150) 
(Supplementary Fig.3, Supplementary Table 7). 
In bowel strictures with and without penetrating diseases—No significant differences in the AUC 
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without penetrating diseases in either the training or test cohort (P=0.744, 0.149, respectively) 
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DISCUSSION 
We developed a novel CTE-based RM for assessment of i testinal fibrostenosis in CD. Our findings 
indicate that an acceptably high diagnostic classificat on efficiency between none-mild and 
moderate-severe intestinal fibrosis in patients with CD can be achieved using our RM, which showed 
remarkable robustness in agreement among three indepe nt institutions and in bowel segments with 
different inflammatory severity. Additionally, our RM significantly outperformed 
radiologist-performed visual interpretation in differentiating varying grades of intestinal fibrosis in 
CD. 
The development of radiomics has altered the way radiologists use medical imaging for diagnosis.12 
Radiomics has been successfully applied to evaluate fibrosis of other organs (e.g. the liver).36 
However, to our knowledge, only one study19 has used radiomics analysis to evaluate intestinal 
fibrosis on MRI. CTE, which has high spatial resoluti n, may contribute to accurate delineation of 
bowel contour and VOI segmentation. To date, no study has used CTE-based radiomics to evaluate 
intestinal fibrosis in adult patients with CD. 
Our results filled this gap. In our study, the CTE-based RM was able to differentiate moderate-severe 
from none-mild intestinal fibrosis with moderate diagnostic accuracy. Unlike the study by Tabari et 
al.19, in which three texture features (i.e. mean, skewness and entropy) were selected to predict 
stricture fibrosis, our RM consisted of four busyness texture features with excellent interobserver 
reproducibility. The different imaging modalities (MRI vs. CTE) and predictive tasks (strictures 
with/without fibrosis vs. strictures with none-mild/moderate-severe fibrosis) in these two studies were 
the possible reasons leading to the difference of slected features. These busyness features in our 
study, signifying rapid changes in intensity from one pixel to its neighbour,35 may reflect the spatial 
heterogeneity of collagen deposition within the intestinal strictures. For example, the features of 
"#$##-%'./&01 and "#$##345&01, which reflect the busyness on the transformed images with 
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the RM, while another two features calculated from the images with original or stronger low-frequency 
components have negative weights in the formula.  
Given that various CT scanners and scanning protocols exist in different institutions, assessing RM 
robustness is key to enabling its widespread use. Studies have reported the repeatability and 
reproducibility of radiomic signatures from different CT vendors or different scanning parameters 
with inconsistent results.37-39 Here, although the CTE images were obtained from five different CT 
scanners with respective imaging parameters in three centres, our RM still showed remarkable 
robustness. In the multicentre validation, the RM accuracy in diagnosing intestinal fibrosis did not 
significantly vary among the three centres and the diagnostic RM accuracy of each centre nearly 
matched the overall accuracy. The patients enrolled from these three tertiary referral centres were 
living in all Chinese regions and the CTE images were acquired over a 6-year period. Hence, our RM 
had good generalisation. 
Of note, the performance of this RM for diagnosing i testinal fibrosis was not affected by the 
severity of the superimposed inflammation within the same bowel segment. As known, inflammation 
and fibrosis often coexist in the affected bowel walls in CD,5 and the coexisted inflammation increases 
the difficulty in detecting intestinal fibrosis by conventional imaging analytical strategies. Here, th  
RM accuracy for diagnosing fibrosis in moderate-sever  inflammatory segments was similar to that in 
none-mild inflammatory segments, indicating the stability and reliability of this RM for assessing 
intestinal fibrosis. Additionally, the diagnostic performance of the RM was not affected by the 
presence of penetrating diseases and by the locations of CD (small bowel or colon). As the RM showed 
satisfactory accuracy, excellent robustness, and high stability in diagnosing intestinal fibrosis in the 
training and test cohorts, it may be valuable of clini al generalisation.  
Notably, compared to radiologist-performed visual interpretation, the RM showed a significantly 
higher accuracy in differentiating varying grades of intestinal fibrosis with a better performance in 
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radiologist-performed visual interpretation used aditional evaluation of plain and arterial-phase 
contrast-enhanced CTE. Radiomics analysis has greatly improved the ability of CTE for assessing 
intestinal fibrosis, remedying the limitation of the conventional strategy in interpretation of intestinal 
fibrosis on CT images, as coexisted inflammation can m sk transmural fibrosis. Although we used 
preoperative data to develop the RM, this radiomic signature has potential as a practical imaging 
biomarker to detect bowel fibrosis during clinical management and to personalise the treatment of 
bowel strictures for patients with CD. Moreover, it might be a reliable and non-invasive approach to 
identify the endpoint of clinical trials of anti-fibrosis drugs and to promote the progress of anti-fibrosis 
drugs for patients with CD, because the lack of accurate diagnostic methods for bowel fibrosis may be 
slowing this progress.3, 40 This CTE-based radiomic method has attractive application prospects and 
can benefit patients with CD in primary health care institutions, because other more advanced imaging 
equipment (e.g. MRI scanners) is expensive, whereas radiomics analysis continues to decrease in cost. 
The study had several limitations. First, the sample sizes in the training and test cohorts were limited. 
This is generally a feature of studies using surgical histopathology as a reference standard of bowel 
fibrosis in CD. However, to our knowledge, our study included the largest sample size reported to date 
in a radiomics analysis of bowel fibrosis in CD. In future prospective study, more centres’ data 
collection could sufficiently increase the sample size to strengthen the conclusions. Second, we used 
CTE rather than MR enterography to develop the RM. MR enterography is the preferred examination 
for follow-up of patients with CD as it is non-raditive. However, the complexity of imaging 
technology and parameters of MR enterography increases the difficulty of developing an MR 
enterography–based RM with sufficient robustness, epecially in the case of limited sample sizes. 
Although CTE still has the potential risk of radiation, it is recommended as the preferred method for 
CD patients with acute symptoms or with suspected complex intra-abdominal penetrating diseases.4 
Furthermore, modern low-dose CT scanners have the potential to considerably reduce the ionizing 
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further study; however, developing an RM using CTE first, which would be used for making critical 
decision regarding management and not for repeated us , is a good beginning in the application of 
artificial intelligence for diagnosing intestinal fibrosis in patients with CD. Additionally, in this 
retrospective study, few patients underwent both CTE and MR enterography during the same period. 
Hence, we did not compare the diagnostic performance of a CTE-based RM with that of an MR 
enterography–based RM. Third, this RM might not be applicable for evaluating the fibrotic severity of 
bowel strictures with blurring of the contour, because the diagnostic accuracy of the RM may decrease 
when the bowel contour is difficult to recognize and the outer or lumen of the intestine might be 
incorrectly drawn into the area of interest. Last, manual VOI segmentation for the RM is 
time-consuming, and the development of an automated or semi-automated segmentation tool based on 
deep learning is necessary. Deep learning is an emerging segmentation-free technique in 
computational radiology, and it outperforms radiomics in a variety of tasks. However, more CTE data 
are required to build a robust model during deep learning model training.42 Moreover, due to their 
end-to-end learning design, deep learning models often appear to be black boxes, absorbing data and 
generating output without clear explanations behind their prediction.43 In contrast, the RM in our study 
could be better understood due to the pre-defined radiomic features and simple regression formula. 
Since our RM has achieved a considerable diagnostic performance, a deep learning–based 
segmentation tool, which can encourage the use of the RM in daily clinical practice with optimum 
reproducibility, is worthy of future exploration.  
In conclusion, our RM allows for accurate characterisation of intestinal fibrosis in CD and offers 
notable advantages over radiologist-performed visual interpretation for differentiating varying grades 
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Fig. 1. Flow diagram of the study population.  
(CD, Crohn’s disease; Centre 1, The First Affiliated Hospital of Sun Yat-Sen University; Centre 2, The 
Sixth Affiliated Hospital of Sun Yat-Sen University; Centre 3, Nanfang Hospital of Southern Medical 
University) 
 
Fig. 2. The radiomics analysis workflow. 
(VOI, volume-of-interest; LASSO, least absolute shrinkage and selection operator) 
 
Fig. 3. Images show the radiomics analysis in (A) a 17-year-old girl with CD with moderate-severe 
fibrotic stricture (fibrosis score, 4; inflammation score, 3; predicted probability of RM, over 99.9%), 
and (B) a 34-year-old woman with CD with none-mild fibrotic stricture (fibrosis score, 1; 
inflammation score, 1; predicted probability of RM, below 0.1%). In each part, image (a) shows 
volume rendering reconstruction (blue-green area: intestinal tract; pink area: colonic stricture; red 
area: VOI in the stricture); axial contrast-enhanced v nous-phase CTE image (b) shows a stricture of 
colon (arrowhead); images show Masson’s trichrome (c) and haematoxylin and eosin staining (d), 
respectively (×40 magnification). Illustrations of the four busyness radiomic features overlaid on CTE 
images and their three-dimensional stereogram are as follows: (e) "#$##%&''()*, (f) 
"#$##-%'./&01, (g) "#$##345&01, and (h) "#$##345&51. To generate feature maps, the 
features were calculated for each voxel in the segmented VOIs with a kernel radius of 3 pixels, and the 
value was assigned to the centre pixel. 
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Fig. 4. Diagnostic performance of the radiomic model in the training and test cohorts (A-E). Plots 
show the predicted probabilities of the RM for each bowel lesion in (A) the training cohort (black 
arrow refers to the probability [below 0.1%] of the patient with none-mild fibrotic stricture presented 
in Fig.3B), and in (B) the test cohort (black arrow refers to the probability [over 99.9%] of the patient 
with moderate-severe fibrotic stricture presented in Fig.3A). Plot (C) shows the ROC curves for the 
RM in three independent centres of the test cohort. Plo s show the ROC curves (D) and the calibration 
curves (E) for the RM in both cohorts. 
Comparison of diagnostic performance between the radiomic model and the radiologist-performed 
visual interpretation of CTE images (F-I ). The RM shows a significantly higher AUC in differentiating 
moderate-severe from none-mild intestinal fibrosis than the AUCs of the two radiologists’ visual 
interpretations (all P<0.005 according to DeLong’s test) in (F) the training cohort and (H) the test 
cohort. The decision curve analysis shows that, (G) if the threshold probability is approximately over 
20%, the RM has a higher net benefit than the radiologists’ visual interpretation of the CTE images in 
the training cohort, while (I ) RM always has a higher net benefit than the radiolog sts’ visual 
interpretation in the test cohort. 
(RM, radiomic model; ROC, receiver operating characteristic; CTE; computed-tomography 
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Table 1. Demographic and clinical characteristics in patients with Crohn’s disease 












Sex, n (male/female) 62/25 55/25 19 / 8 23/9 13/8 0.723 
Age, years (mean±SD) 34.36±11.89 34.19±11.41 32.89±10.92 32.38±10.18 38.62±13.06 0.926 
Disease duration, months (median [IQR]) 36 (12-72) 36 (14.25-72) 37 (18-72) 58.50(25.25-105) 18 (6-30) 0.413 
Interval between CT and surgery, days (median [IQR]) 14 (9-28) 14 (10-24) 19 (11-34) 14 (10.25-21.50) 11 (7.50-15) 0.604 
Smoking, n (%)  21 (24.14%) 15 (18.75%) 6 (22.22%) 2 (6.25%) 7 (33.33%) 0.398 
BMI (median [IQR]) 16.80 (15.10-18.90) 18.20 (16.06-20.47) 18 (16-19.20) 18.60 (17.08-21.18) 18.50 (15.49-20.94) 0.067 
Previous surgery history, n (%)      0.654 
  CD-associated bowel resection 12 (13.79%) 10 (12.50%) 0 6 (18.75%) 4 (19.05%) -- 
  Perianal surgery 12 (13.79%) 9 (11.25%) 5 (18.52%) 4 (12.50%) 0 -- 
Type of surgery in the present study, n (%)      0.001 
Ileocolic resection 42 (48.28%) 18 (22.5%) 13 (48.15%) 1 (3.13%) 4 (19.05%) -- 
Partial small bowel resection 19 (21.84%) 13 (16.25%) 3 (11.11%) 4 (12.50%) 6 (28.57%) -- 
Partial colon resection  9 (10.34%) 13 (16.25%) 7 (25.93%) 4 (12.50%) 2 (9.52%) -- 
Ileocolic + Partial small bowel resection 12 (13.79%) 14 (17.50%) 2 (7.41%) 12 (37.50%) 0 -- 
Ileocolic + Partial colon resection 3 (3.45%) 12 (15%) 0  5 (15.63%) 7 (33.33%) -- 
Partial small bowel + Partial colon resection 2 (2.30%) 10 (12.50%) 2 (7.41%) 6 (18.75%) 2 (9.52%) -- 
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Small bowel 92 (93.88%) 90 (78.95%) 56 (91.81%) 21 (65.62%) 13 (61.90%) -- 
Colon 6 (6.12%) 24 (21.05%) 5 (8.20%) 11 (34.38%) 8 (38.10%) -- 
CDAI, n (%)      ＜0.001 
< 150 (remission) 13 (14.94%) 21 (26.25%) 4 (14.81%) 9 (33.33%) 8 (38.10%) -- 
  150-220 (mild activity) 13 (14.94%) 29 (36.25%) 9 (33.33%) 14 (43.75%) 6 (28.57%) -- 
  220-450 (moderate activity) 54 (62.07%) 28 (35%) 13 (48.15%) 8 (25%) 7 (33.33%) -- 
> 450 (severe activity) 7 (8.05%) 2 (2.50%) 1 (3.70%) 1 (3.70%) 0 -- 
CRP, mg/L (median [IQR]) 26.10 (8.31-77.60) 16.29 (5.63-54.77) 29.50 (9.42-56.48) 8.88 (3.01-18.05) 49.52 (8.94-95.96) 0.814 
ESR, mm/h (median [IQR]) 37 (19-53) 35 (13.50-50) 40 (13-51) 22 (14-45) 42 (11.70-80) 0.610 
BMI, Body mass index; CDAI, Crohn’s disease activity index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IQR, interquartile range; SD, standard deviation 
# Number of involving bowel segments 
* Centre 1, The First Affiliated Hospital of Sun Yat-Sen University; Centre 2, The Sixth Affiliated Hospital of Sun Yat-Sen University; Centre 3, Nanfang Hospital of Southern 
Medical University 
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Table 2. Diagnostic performances of the radiomic model and radiologists’ visual interpretation in differentiating  
moderate-severe from none-mild intestinal fibrosis in the training cohort and the total test cohort 
 
 AUC (95%CI) Accuracy Sensitivity Specificity P 
Training cohort (n=98#)      
Radiomic Model      
Overall 0.888 (0.818-0.957) 0.857 0.815 0.939 <0.001 
Inflammatory severity      
None-mild 0.836 (0.580-1.000) 0.813 0.818 0.800 0.01  
Moderate-severe 0.890 (0.813-0.966) 0.866 0.815 0.964 <0.001 
Visual Interpretation      
Radiologist 1 0.508 (0.388-0.629) 0.582 0.646 0.455 0.892 
Radiologist 2 0.567 (0.448-0.686) 0.531 0.477 0.636 0.281 
Test cohort (n=114#)      
Radiomic Model      
Overall 0.832 (0.745-0.919) 0.833 0.902 0.656 <0.001 
Inflammatory severity      
None-mild 0.829 (0.683-0.926) 0.721 0.750 0.704 <0.001 
Moderate-severe 0.785 (0.671-0.874) 0.901 0.939 0.400 <0.001 
Visual Interpretation      
Radiologist 1 0.554 (0.458-0.647) 0.570 0.561 0.594 0.354 
Radiologist 2 0.598 (0.502-0.689) 0.649 0.585 0.813 0.071 
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Accuracy, sensitivity, and specificity of the radiomic model in training and test cohorts were calculated with the cut-off value of 0.811, which maximizes the 
Youden index in the training cohort.  
P value is the significance level of comparison of AUC with that of random case (AUC=0.5) 
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Table 3. Diagnostic performances of the radiomic model and radiologists’ visual interpretation in the independent test cohort of three centres  
 
 AUC (95%CI) Accuracy Sensitivity Specificity P 
Centre 1# (n=61*)       
Radiomic Model 0.816 (0.706-0.926) 0.754 0.818 0.679 <0.001 
Visual Interpretation      
Radiologist 1 0.558 (0.413-0.703) 0.574 0.515 0.643 0.628 
Radiologist 2 0.536 (0.390-0.683) 0.590 0.606 0.571 0.439 
Centre 2# (n=32*)      
Radiomic Model 0.724 (0.526-0.923) 0.906 1.000 0 0.027 
Visual Interpretation      
Radiologist 1 0.546 (0.361-0.722) 0.719 0.759 0.333 0.834 
Radiologist 2 0.511 (0.329-0.691) 0.375 0.345 0.667 0.962 
Centre 3# (n=21*)      
Radiomic Model 0.750 (0.560-0.940) 0.857 0.900 0 0.409 
Visual Interpretation      
Radiologist 1 0.650 (0.441-0.859) 0.381 0.350 1.000 0.620 
Radiologist 2 0.525 (0.194-0.856) 0.333 0.300 1.000 0.934 
Note. AUC, area under receiver operating characteristic curve; CI, confidence interval 
Accuracy, sensitivity, and specificity of the radiomic model in three centres were calculated with the cut-off value of 0.811, which maximizes the Youden index 
in the training cohort.  
P value is the significance level of comparison of AUC with that of random case (AUC=0.5) 
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# Centre 1, The First Affiliated Hospital of Sun Yat-Sen University; Centre 2, The Sixth Affiliated Hospital of Sun Yat-Sen University; Centre 3, Nanfang 
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115 CD patients from centre 1
initially included in training cohort
Inadequate imaging quality: n=5
Final study population in training cohort:
87 patients with 98 bowel specimens Radiomic model
Develop Validate Final study population in test cohort:
80 patients with 114 bowel specimens
• Centre 1: 27 patients with 61 specimens
• Centre 2: 32 patients with 32 specimens
• Centre 3: 21 patients with 21 specimens
105 CD patients from three centres
initially included in test cohort
(Centre 1, n=30; Centre 2, n=37; Centre 3, n=38)
Targeted bowel segment located 
at an anastomosis: n=8
Targeted bowel segment located 
at an anastomosis: n=13
Patients without enhanced CT 
scanning: n=2
Not readily identifiable 
intestinal contour on CTE: n=8
Inadequate imaging quality: n=6
Not readily identifiable 
intestinal contour on CTE: n=10
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What You Need to Know 
Background and Context 
Accurate characterisation of intestinal fibrostenosis i  crucial for the management of 
Crohn’s disease (CD); however, no consensus currently xists regarding the most 
reliable method for evaluating intestinal fibrosis in CD. 
New Findings 
A novel computed-tomography enterography (CTE)-based radiomic model allowed 
for accurate characterisation of intestinal fibrosis in CD with remarkable robustness 
across different centres. Diagnostic performance was not affected by coexisting 
inflammation.  
Limitations  
The study is limited by its retrospective design. Furthermore, data from more centres 
is needed to confirm the diagnostic performance of this radiomic model. 
Impact 
This radiomic model improves the performance of CTE for transmural fibrosis 
quantitation in patients with CD; the model may be us ful for improving patient care 
while decreasing healthcare costs. 
 
Short summary 
Our imaging model allows for accurate characterisation of intestinal fibrosis in 
Crohn’s disease. Importantly, the model was robust across different treatment centres 
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